​POA Pharma Scandinavia AB signs distribution agreement with Orpharma, Melbourne, Australia

POA Pharma Scandinavia AB signs distribution agreement with Orpharma, Melbourne, Australia for marketing and sale of POA Pharma´s products within the competence area, Inborn Error of Metabolism in Australia and New Zeeland.

”The market for products defined as Food for specific Medical purposes or Medical Nutrition is a very interesting and fast growing market all over the world and POA intends to be among the leading companies regarding these interesting areas.Orpharma with its experiences in rare metabolic diseases are a perfect match”, says Tina Madsen Sandström, CEO at the POA group.

Orpharma is an Australian pharmaceutical company focused on the supply of orphan, paediatric and emerging therapeutics. The company was founded to serve unmet medical needs and to provide niche solutions. Orpharma is collaborating with global leaders in biotechnology and pharmaceuticals to deliver therapies to patients in need. Giving a ray of hope.

Orpharma’s current product portfolio includes innovative medicines targeting rare metabolic diseases, cancer and anti-infective.

“We are excited to bring POA’s niche products in our assigned jurisdictions. The PKU and UCD range complements our portfolio of existing products in inborn errors of metabolism.” said Dr Hala Raghib, Chief Executive Officer of Orpharma. “We continue to focus on bringing solutions for unmet needs to patients”.

POA Pharma – The Boutique Healthcare Company

Brief History

POA Pharma was on the market March 2011. Today the company have offices in four Nordic countries and in US. POA Pharma works within nine different competence areas having export agreements with 30 countries and agreements with pharmaceutical producers in 11 countries.

An Export Company.

Since 2013, POA Pharma have signed distribution agreements for it´s metabolic assortment in 27 countries; Australia, Argentina, Bolivia, Botswana, Brazil, Canada, Chile, Colombia, Czech Republic, Holland, Honduras, 
Ireland, Island, Italy, Malaysia, Mexico
, Mozambique, Namibia, New Zeeland, Singapore, Slovakia,
 South Africa, Turkey
, UK, USA,
 Uruguay, Zimbabwe,

A Boutique Company

POA Pharma is a market oriented Boutique Healthcare Company, working in close contact with healthcare organizations, professionals and pharmacies in the 26 million population Nordic countries.

Boutique is French for "shop", via Latin from Greek apothēkē, "sto, rehouse". In contemporary business language boutique is a specialized firm with a unique concept.

“ A Boutique is where you expect to be positive surprised when finding what the average shop cannot offer. “

For more information please contact:

Tina Madsen Sandström,tina.sandstrom@poaab.com or Hala Raghib, hala.raghib@orpharma.com